Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Erythromycin and diffuse panbronchiolitis.

Literature DB >> 9404381

Erythromycin and diffuse panbronchiolitis.

H Koyama¹, D M Geddes.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 1997 PMID： 9404381 PMCID： PMC1758435 DOI： 10.1136/thx.52.10.915

Source DB: PubMed Journal: Thorax ISSN： 0040-6376 Impact factor: 9.139

× No keyword cloud information.

41 in total

1. [A case of diffuse panbronchiolitis relieved rapidly by the treatment of roxithromycin].

Authors: J Ashitani; Y Doutsu; T Ii; H Taniguchi; S Matsukura
Journal: Kansenshogaku Zasshi Date: 1992-05

2. Diffuse panbronchiolitis in an Asian immigrant.

Authors: O Brugiere; B Milleron; M Antoine; M F Carette; C Philippe; C Mayaud
Journal: Thorax Date: 1996-10 Impact factor: 9.139

3. [The long term chemotherapy with erythromycin in chronic lower respiratory tract infections--first report: comparison with amoxicillin].

Authors: M Sawaki; R Mikami; K Mikasa; M Kunimatsu; S Ito; N Narita
Journal: Kansenshogaku Zasshi Date: 1986-01

4. [The long term chemotherapy with erythromycin in chronic lower respiratory tract infections--second report: including cases with Pseudomonas infections].

Authors: M Sawaki; R Mikami; K Mikasa; M Kunimatsu; S Ito; N Narita
Journal: Kansenshogaku Zasshi Date: 1986-01

5. Diffuse panbronchiolitis: efficacy of low-dose erythromycin.

Authors: J Tredaniel; G Zalcman; F Gerber; M F D'Agay; F Capron; J Frija; A Hirsch
Journal: Respir Med Date: 1993-04 Impact factor: 3.415

6. [Familial occurrence of diffuse panbronchiolitis accompanied with elevation of cold agglutinin titer in a father and his two daughters].

Authors: T Danbara; R Matsuoka; T Nukiwa; H Natori; T Arai; S Kira
Journal: Nihon Kyobu Shikkan Gakkai Zasshi Date: 1982-05

7. Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients.

Authors: Y Ichikawa; H Ninomiya; H Koga; M Tanaka; M Kinoshita; N Tokunaga; T Yano; K Oizumi
Journal: Am Rev Respir Dis Date: 1992-07

8. Macrolides and immunity: effects of erythromycin and spiramycin on human mononuclear cell proliferation.

Authors: Y Roche; M A Gougerot-Pocidalo; M Fay; N Forest; J J Pocidalo
Journal: J Antimicrob Chemother Date: 1986-02 Impact factor: 5.790

9. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis.

Authors: J Kadota; O Sakito; S Kohno; H Sawa; H Mukae; H Oda; K Kawakami; K Fukushima; K Hiratani; K Hara
Journal: Am Rev Respir Dis Date: 1993-01

10. [A study to clarify the mechanism of the usefulness of the macrolides--the influence of clarithromycin to biofilm with P. aeruginosa].

Authors: H Takeda; N Oogaki; N Kikuchi; H Kobayashi; T Akashi
Journal: Kansenshogaku Zasshi Date: 1992-10

15 in total

1. Evaluation and management of pulmonary disease in ataxia-telangiectasia.

Authors: Sharon A McGrath-Morrow; W Adam Gower; Cynthia Rothblum-Oviatt; Alan S Brody; Claire Langston; Leland L Fan; Maureen A Lefton-Greif; Thomas O Crawford; Michelle Troche; John T Sandlund; Paul G Auwaerter; Blaine Easley; Gerald M Loughlin; John L Carroll; Howard M Lederman
Journal: Pediatr Pulmonol Date: 2010-09

Erythromycin and diffuse panbronchiolitis.

1. [A case of diffuse panbronchiolitis relieved rapidly by the treatment of roxithromycin].

2. Diffuse panbronchiolitis in an Asian immigrant.

3. [The long term chemotherapy with erythromycin in chronic lower respiratory tract infections--first report: comparison with amoxicillin].

4. [The long term chemotherapy with erythromycin in chronic lower respiratory tract infections--second report: including cases with Pseudomonas infections].

5. Diffuse panbronchiolitis: efficacy of low-dose erythromycin.

6. [Familial occurrence of diffuse panbronchiolitis accompanied with elevation of cold agglutinin titer in a father and his two daughters].

7. Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients.

8. Macrolides and immunity: effects of erythromycin and spiramycin on human mononuclear cell proliferation.

9. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis.

10. [A study to clarify the mechanism of the usefulness of the macrolides--the influence of clarithromycin to biofilm with P. aeruginosa].

1. Evaluation and management of pulmonary disease in ataxia-telangiectasia.

2. Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae.

3. Macrolide therapy in airways disease.

4. Erythromycin modulates eosinophil chemotactic cytokine production by human lung fibroblasts in vitro.

5. Efficacy of periprosthetic erythromycin delivery for wear debris-induced inflammation and osteolysis.

Review 6. Use of modulators of airways inflammation in patients with CF.

7. Advantages and drawbacks of long-term macrolide use in the treatment of non-cystic fibrosis bronchiectasis.

8. Azithromycin attenuates airway inflammation in a mouse model of viral bronchiolitis.

Review 9. Pathogen- and host-directed anti-inflammatory activities of macrolide antibiotics.

Review 10. Role of macrolide therapy in chronic obstructive pulmonary disease.